Browsing by Author "Gao, Q"
Now showing items 1-7 of 7
-
Controlled Intracellular Polymerization for Cancer Treatment
Zhang, Y; Gao, Q; Li, W; He, R; Zhu, L; Lian, Q; Wang, L; Li, Y; Bradley, M; Geng, J (2022) -
Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas
Ma, H; Dai, H; Duan, X; Tang, Z; Liu, R; Sun, K; Zhou, K; Chen, H; Xiang, H; Wang, J (2016-08-23) -
Light-mediated intracellular polymerization.
Abdelrahim, M; Gao, Q; Zhang, Y; Li, W; Xing, Q; Bradley, M; Geng, J (2024-03-21)The synthesis of synthetic intracellular polymers offers groundbreaking possibilities in cellular biology and medical research, allowing for novel experiments in drug delivery, bioimaging and targeted cancer therapies. ... -
Microcellular epoxy/graphene nanocomposites with outstanding electromagnetic interference shielding and mechanical performance by overcoming nanofiller loading/dispersion dichotomy
Fan, X; Gao, Q; Gao, Y; Zhang, G; Huang, F; Xiao, R; Liu, W; Wang, F; Qin, J; Bilotti, E (Elsevier BV, 2021-08)With the rapid evolvement of wireless communication technologies, the ever increasing needs to prevent electromagnetic waves (EMWs) pollution have urged the development of lightweight materials with excellent electromagnetic ... -
Nature inspired hierarchical structures in nano-cellular epoxy/graphene-Fe3O4 nanocomposites with ultra-efficient EMI and robust mechanical strength
Fan, X; Wang, F; Gao, Q; Zhang, Y; Huang, F; Xiao, R; Qin, J; Zhang, H; Shi, X; Zhang, G (Elsevier, 2021-08)Hierarchical layered structures, whether in a compact form like nacre or a porous manner like bone, are well known for their combined features of high stiffness, strength, and lightweight, inspiring many man-made materials ... -
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Buus, R; Yeo, B; Brentnall, AR; Klintman, M; Cheang, MCU; Khabra, K; Sestak, I; Gao, Q; Cuzick, J; Dowsett, M (2018-09-04)BACKGROUND: Several prognostic signatures for early oestrogen receptor-positive (ER+) breast cancer have been established with a 10-year follow-up. We tested the hypothesis that signatures optimised for 0-5-year and 5-10-year ... -
Switching on prodrugs using radiotherapy
Geng, J; Zhang, Y; Gao, Q; Neumann, K; Dong, H; Porter, H; Potter, M; Ren, H; Argyle, D; Bradley, M (2021)